within Pharmacolibrary.Drugs.ATC.P;

model P02BA01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 6.666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.007166666666666667,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.00085,
    k12             = 26,
    k21             = 26
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>P02BA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Praziquantel is an anthelmintic agent primarily used to treat parasitic worm infections such as schistosomiasis and other fluke infestations. It is approved and widely used today for both human and veterinary medicine.</p><h4>Pharmacokinetics</h4><p>Adult healthy volunteers, after single oral administration.</p><h4>References</h4><ol><li><p>Arion, A, et al., &amp; Ognean, L (2018). Pharmacokinetics of praziquantel and pyrantel pamoate combination following oral administration in cats. <i>Journal of feline medicine and surgery</i> 20(10) 900–904. DOI:<a href=&quot;https://doi.org/10.1177/1098612X17734065&quot;>10.1177/1098612X17734065</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29017390/&quot;>https://pubmed.ncbi.nlm.nih.gov/29017390</a></p></li><li><p>Dobsikova, R, et al., &amp; Velisek, J (2024). Pharmacokinetics of praziquantel and its metabolites in grass carp (. <i>Veterinarni medicina</i> 69(2) 52–60. DOI:<a href=&quot;https://doi.org/10.17221/109/2023-VETMED&quot;>10.17221/109/2023-VETMED</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38550621/&quot;>https://pubmed.ncbi.nlm.nih.gov/38550621</a></p></li><li><p>Amara, RO, et al., &amp; El-Khordagui, LK (2018). Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential . <i>International journal of nanomedicine</i> 13 4493–4505. DOI:<a href=&quot;https://doi.org/10.2147/IJN.S167285&quot;>10.2147/IJN.S167285</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30122922/&quot;>https://pubmed.ncbi.nlm.nih.gov/30122922</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end P02BA01;
